Results 101 to 110 of about 2,293 (194)

[Clinical and microbiological effectiveness of Helicobacter pylori eradication treatment with triple therapy]. [PDF]

open access: yesAten Primaria
Ghandour Fawaz Y   +5 more
europepmc   +1 more source

[Hepatic encephalopathy from cholangitis in a young patient with ornithine transcarbamylase mutation]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Rojas-Salazar YL   +2 more
europepmc   +1 more source

Polychlorinated biphenyls (PCBs) interact with drug metabolism in vivo. [PDF]

open access: yesArch Toxicol
Müller JP   +16 more
europepmc   +1 more source

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy. [PDF]

open access: yesSignal Transduct Target Ther
Deiman FE   +18 more
europepmc   +1 more source

Pharmacologic Stewardship in a Rural Community Pharmacy. [PDF]

open access: yesHealthcare (Basel), 2023
Sardeli C   +3 more
europepmc   +1 more source

Avaliação comparativa do perfil de dissolução in vitro de microgrânulos gastrorresistentes de omeprazol para desenvolvimento de medicamento similar

open access: yes, 2014
O omeprazol é um inibidor da bomba de próton utilizado no tratamento do refluxo gastroesofágico, síndrome de Zollinger-Ellison e úlcera péptica. Uma vez que é instável em pH ácido, a matéria-prima omeprazol é comumente comercializada na forma de ...
Testa, Carla Giordani   +1 more
core  

Adequacy of the Type of Venous Catheter to the Drug Type and Duration of Treatment: A Cross-Sectional Study. [PDF]

open access: yesNurs Rep
Moreno-Rubio E   +6 more
europepmc   +1 more source

[New tools for medication review: DRP in patients treatment with proton pump inhibitors]. [PDF]

open access: yesAten Primaria
Gutiérrez-Igual S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy